Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma
Open Access
- 1 January 2016
- journal article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 7 (7) , 823-830
Abstract
Background: The prognosis of angiosarcoma is poor and a novel treatment option for the disease is desired. The aim of this study was to investigate the prognostic significance of Forkhead box M1 (FOXM1), a transcription factor that regulates cell-cycle progression and various crucial processes in tumor progression, and its potential as a new therapeutic target.Keywords
This publication has 26 references indexed in Scilit:
- Targeting FOXM1 in cancerBiochemical Pharmacology, 2013
- Cancer genetics and genomics of human FOX family genesCancer Letters, 2013
- Thiazole Antibiotics Siomycin a and Thiostrepton Inhibit the Transcriptional Activity of FOXM1Frontiers in Oncology, 2013
- Phase II Studies in Soft Tissue Sarcoma: Time for ReappraisalThe Oncologist, 2012
- Cutaneous angiosarcoma. Analysis of 434 cases from the Surveillance, Epidemiology, and End Results Program, 1973-2007Annals of Diagnostic Pathology, 2011
- Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 casesAnnals of Oncology, 2007
- Treatment and Outcome of 82 Patients with AngiosarcomaAnnals of Surgical Oncology, 2007
- Chromosomal aberrations and microsatellite instability of malignant peripheral nerve sheath tumors: a study of 10 tumors from nine patientsCancer Genetics and Cytogenetics, 2006
- A 14-Year Retrospective Review of AngiosarcomaThe Cancer Journal, 2005
- Identification and Validation of Commonly Overexpressed Genes in Solid Tumors by Comparison of Microarray DataNeoplasia, 2004